Lowered DHEA-S plasma levels in adult individuals with autistic disorder

European Neuropsychopharmacology

Volumn 15, Issue 3, 2005, Pages 305-309

  Strous, Rael D ^a,b   Golubchik, Pavel ^c   Maayan, Rachel ^b   Mozes, Tamar ^b,c   Tuati Werner, Dafna ^b   Weizman, Abraham ^b,d   Spivak, Baruch ^b,c  

^a BEER YAAKOV MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c NESS ZIONA MENTAL HEALTH CENTER   (Israel)

^d GEHA MENTAL HEALTH CENTER   (Israel)

Author keywords

Aggression; Autism; Autistic disorder; Dehydroepiandrosterone; DHEA; DHEA S; Neurosteroid

Indexed keywords

HYDROCORTISONE; NEUROSTEROID; PRASTERONE; PRASTERONE SULFATE;

ADULT; ARTICLE; AUTISM; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; OVERT AGGRESSION SCALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RATING SCALE; RITVO FREEMAN REAL LIFE RATING SCALE; STATISTICAL SIGNIFICANCE; STEROID BLOOD LEVEL; SYMPTOM;

EID: 16844363517     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2004.12.004     Document Type: Article

References (39)

1. G.M. Anderson Monoamines in autism: an update of neurochemical research on a pervasive developmental disorder Med. Biol. 65 1985 67 74
2. M.L. Barbaccia, D. Affricano, R.H. Purdy, E. Maciocco, F. Spiga, and G. Biggio Clozapine, but not haloperidol, increases brain concentrations of neuroactive steroids in the rat Neuropsychopharmacology 25 2001 489 497
3. S. Bastianetto, C. Ramassamy, J. Poirier, and R. Quirion Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage Mol. Brain Res. 66 1999 35 41
4. E.E. Baulieu, and P. Robel Dehydroepiandrosterone and dehydroepiandrosterone sulfate as neuroactive neurosteroids J. Endocrinol. 150 1996 S221 S239
5. R. Bergeron, C. de Montigny, and G. Debonnel Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors J. Neurosci. 16 1996 1193 1202
6. J.K. Buitelaar, and S.H. Willemsen-Swinkels Autism: current theories regarding its pathogenesis and implications for rational pharmacotherapy Paediatr. Drugs 2 2000 67 81
7. A. Cardounel, W. Regelson, and M. Kalimi Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action Proc. Soc. Exp. Biol. Med. 222 1999 145 149
8. M.L. Carlsson Hypothesis: is infantile autism a hypoglutamatergic disorder? Relevance of glutamate-serotonin interactions for pharmacotherapy J. Neural Transm. 105 1998 525 535
9. D.C. Chugani Role of altered brain serotonin mechanisms in autism Mol. Psychiatry 7 Suppl 2 2002 S16 S17
10. B.I. Cohen GABA-transaminase, the liver and infantile autism Med. Hypotheses 57 2001 673 674
11. N.A. Compagnone, and S.H. Mellon Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development Proc. Natl. Acad. Sci. U. S. A. 95 1998 4678 4683
12. C. Corpechot, P. Robel, M. Axelson, J. Sjovall, and E.E. Baulieu Characterization and measurement of dehydroepiandrosterone sulfate in rat brain Proc. Natl. Acad. Sci. U. S. A. 78 1981 4704 4707
13. E. Courchesne, C.M. Karns, H.R. Davis, R. Ziccardi, R.A. Carper, Z.D. Tigue, H.J. Chisum, P. Moses, K. Pierce, C. Lord, A.J. Lincoln, S. Pizzo, L. Schreibman, R.H. Haas, N.A. Akshoomoff, and R.Y. Courchesne Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study Neurology 57 2001 245 254
14. J.T. Coyle The glutamatergic dysfunction hypothesis for schizophrenia Harv. Rev. Psychiatry 3 1996 241 253
15. S. Demirgoren, M.D. Majewska, C.E. Spivak, and E.D. London Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor Neuroscience 45 1991 127 135
16. D. Dhossche, H. Applegate, A. Abraham, P. Maertens, L. Bland, A. Bencsath, and J. Martinez Elevated plasma gamma-aminobutyric acid (GABA) levels in autistic youngsters: stimulus for a GABA hypothesis of autism Med. Sci. Monit. 8 2002 1 6
17. M.B. First, R.L. Spitzer, M. Gibbon, and J.S.W. Williams Structured clinical interview for axis I DSM-IV disorders, patients version (SCID-P), Hebrew version 1994 Jakobsohn Tel Aviv
18. B.J. Freeman, E.R. Ritvo, A. Yokota, and A. Ritvo A scale for rating symptoms of patients with the syndrome of autism in real life settings J. Am. Acad. Child Psych. 25 1986 130 136
19. E. Friess, T. Schiffelholz, T. Steckler, and A. Steiger Dehydroepiandrosterone-a neurosteroid Eur. J. Clin. Invest. 30 Suppl 3 2000 46 50
20. D.C. Javitt, and S.R. Zukin Recent advances in the phencyclidine model of schizophrenia Am. J. Psychiatry 148 1991 1301 1308
21. V.G. Kimonides, N.H. Khatibi, C.N. Svendsen, M.V. Sofroniew, and J. Herbert Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity Proc. Natl. Acad. Sci. U. S. A. 95 1998 1852 1857
22. P.D. Kroboth, F.S. Salek, A.L. Pittenger, T.J. Fabian, and R.F. Frye DHEA and DHEA-S: a review J. Clin. Pharmacol. 39 1999 327 348
23. P.A. Lapchak, and D.M. Araujo Preclinical development of neurosteroids as neuroprotective agents for the treatment of neurodegenerative diseases Int. Rev. Neurobiol. 46 2001 379 397
24. W. Leowattana DHEAS as a new diagnostic tool Clin. Chim. Acta 341 2004 1 15
25. C. Lord, M. Rutter, and A. Le Couteur Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders J. Autism Dev. Disord. 24 1994 659 685
26. M.D. Majewska, S. Demirgoren, C.E. Spivak, and E.D. London The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor Brain Res. 526 1990 143 146
27. F. Marrosu, G. Marrosu, M.G. Rachel, and G. Biggio Paradoxical reactions elicited by diazepam in children with classic autism Funct. Neurology 2 1987 355 361
28. E.R. Martin, M.M. Menold, C.M. Wolpert, M.P. Bass, S.L. Donnelly, S.A. Ravan, A. Zimmerman, J.R. Gilbert, J.M. Vance, L.O. Maddox, H.H. Wright, R.K. Abramson, G.R. DeLong, M.L. Cuccaro, and M.A. Pericak-Vance Analysis of linkage disequilibrium in gamma-aminobutyric acid receptor subunit genes in autistic disorder Am. J. Med. Genet. 96 2000 43 48
29. C.E. Marx, G.E. Duncan, J.H. Gilmore, J.A. Lieberman, and A.L. Morrow Olanzapine increases allopregnanolone in the rat cerebral cortex Biol. Psychiatry 47 2000 1000 1004
30. G.B. Mesibov, E. Schopler, B. Schaffer, and N. Michal Use of the childhood autism rating scale with autistic adolescents and adults J. Am. Acad. Child Adolesc. Psych. 28 1989 538 541
31. F.P. Monnet, V. Mahe, P. Robel, and E.E. Baulieu Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-d-aspartate in the rat hippocampus Proc. Natl. Acad. Sci. U. S. A. 92 1995 3774 3778
32. I. Olsson, S. Steffenburg, and C. Gillberg Epilepsy in autism and autistic-like conditions. A population-based study Arch. Neurol. 45 1988 666 668
33. N. Orentreich, J.L. Brind, R.L. Rizer, and J.H. Vogelman Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood J. Clin. Endocrinol. Metab. 59 1984 551 555
34. S.M. Paul, and R.H. Purdy Neuroactive steroids FASEB J. 6 1992 2311 2322
35. M.G. Pisu, and M. Serra Neurosteroids and neuroactive drugs in mental disorders Life Sci. 74 2004 3181 3197
36. R. Rupprecht, F. di Michele, B. Hermann, A. Strohle, M. Lancel, E. Romeo, and F. Holsboer Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology Brain Res. Rev. 37 2001 59 67
37. S. Tordjman, G.M. Anderson, P.A. McBride, M.E. Hertzig, M.E. Snow, L.M. Hall, P. Ferrari, and D.J. Cohen Plasma androgens in autism J. Autism Dev. Disord. 25 1995 295 304
38. F. van Broekhoven, and R.J. Verkes Neurosteroids in depression: a review Psychopharmacology 165 2003 97 110
39. S.C. Yudofsky, J.M. Silver, W. Jackson, J. Endicott, and D. Williams The Overt Aggression Scale for the objective rating of verbal and physical aggression Am. J. Psychiatry 143 1986 35 39